Dana-Farber Cancer Institute

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Dana-Farber Cancer Institute
May 30, 2025, 18:31 | Blog
Paolo Tarantino: Pleased to Welcome Prof. Al-Shamsi to Dana-Farber Cancer Institute
Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Huge pleasure…
May 24, 2025, 17:46 | Insight
Paolo Tarantino on HER2 advances at Nordic Pathology Meeting 2025
Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, shared a post by Svensk Förening…
May 22, 2025, 06:58 | Blog
Pratiti Bandopadhayay: Joining Editorial Team of New Journal on Pediatric Brain Tumors
Pratiti Bandopadhayay, Pediatric Neuro-Oncologist at Dana-Farber Cancer Institute and Broad Institute, shared a post on LinkedIn:…
May 21, 2025, 16:57 | Science
Guru Sonpavde: CheckMate 901 Trial Data on First-Line Nivolumab in LN-Only Metastatic Urothelial Carcinoma
Guru Sonpavde, GU Oncology and Phase I Clinical Trials Director, Chair of Bladder Cancer Research…
May 20, 2025, 10:09 | Blog
Antonio Giordano: Benefit of CDK4/6i in HER2+ MBC
Antonio Giordano, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared a post on X: "More evidence…
May 20, 2025, 02:46 | Blog
Narjust Florez Honored as 2025 Rising Star Woman in Healthcare
Some journeys are marked by an extraordinary sense of purpose—and Dr. Narjust Florez’s path is…
May 17, 2025, 07:45 | Blog
Mane Gizhlaryan: My Last Day of Training at Dana-Farber Cancer Institute and Boston Children’s Hospital
Mane Gizhlaryan, Pediatric Hematologist-Oncologist and HSCT specialist at Yeolyan Hematology and Oncology Center, shared a…
May 16, 2025, 10:07 | Blog
A Conversation Centered on AI, Early Detection, and Breakthrough Therapies Shaping the Future of Oncology - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Cancer care is changing. Fast. What does the…
May 15, 2025, 15:11 | Blog
Estela Rodriguez: Celebrating our ECOG-ACRIN Cancer Research Group statisticians like Yating Wang
Estela Rodriguez, Associate Director of Community Outreach and Co-Lead Thoracic Site Disease Group of the Sylvester…
May 15, 2025, 14:51 | Blog
Pablo Mando: T-DXd demonstrated benefit over Capecitabine and Taxane in HR+/HER2- MBC
Pablo Mando, Editor-in-Chief of Oncologia Clínica, shared a post on X: "Great presentation by Carlos Barrios…
May 12, 2025, 11:05 | Blog
Duncan Finigan’s Legacy in Breast Cancer Fundraising - The Jimmy Fund
The Jimmy Fund shared a post on X: "Duncan Finigan, a beloved mother, wife, friend and…
May 6, 2025, 12:56 | Blog
Subear Hussein: Honored to present my research at the 1st National Undergraduate Research Conference at Brown University
Subear Hussein, Student Researcher at Dana-Farber Cancer Institute, shared a post on LinkedIn: "This past…
May 6, 2025, 10:46 | Blog
Narjust Florez Leads Talk on Sexual Health at LUNGevity Hope Summit
Narjust Florez, Co Director Young Lung Cancer Program at Dana-Farber Cancer Institute, shared on X:…
May 6, 2025, 08:53 | Blog
CancerWorld Highlights Dr. Philip Kantoff’s Legacy in Oncology Leadership and Mentorship
CancerWorld posted on LinkedIn: "In the April issue of CancerWorld, we spotlight Dr. Philip Kantoff,…
May 2, 2025, 08:26 | Insight
Melanya Sahakyan: 2 month of growth and inspiration at Dana-Farber Cancer Institute
Melanya Sahakyan shared a post on Facebook: "Today marks the end of my two-month observership…
Apr 25, 2025, 12:33 | Blog
Paolo Tarantino: Two practice-changing ADC phase 3 trials announced to be positive
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "2025 is…
Apr 24, 2025, 18:30 | Blog
Paolo Tarantino: Recent ADCs took a median time of 7 years from clinical introduction to approval
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared Lavinia Woodward's post on LinkedIn, adding:…
Apr 23, 2025, 10:07 | Blog
Paolo Tarantino: ADCs are rapidly moving to earlier line treatment for breast cancer
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on LinkedIn: "ADCs are rapidly…
Apr 22, 2025, 06:34 | Blog
Join Florez Lab's Lung Cancer Team as they walk for hope, healing, and a future without lung cancer
Florez Lab posted on X: "Strolling through the halls of Dana-Farber and the legacy of…
Apr 22, 2025, 05:37 | Blog
Dana-Farber Cancer Institute - Benjamin L. Ebert was recognized with the Erasmus Hematology Award
Dana-Farber Cancer Institute posted on LinkedIn: "Our President and CEO Benjamin L. Ebert, MD, PhD,…
Apr 20, 2025, 15:38 | Blog
Larissa Nekhlyudov: Raising awareness about cancer survivorship in spring and early summer 2025
Larissa Nekhlyudov, Professor of Medicine at Brigham and Women's Hospital, Dana-Farber Cancer Institute, Harvard Medical…
Apr 14, 2025, 09:13 | Stories
The role of physical activity in lymphedema after breast cancer surgery - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "After her breast cancer surgery, Tia struggled…
Apr 13, 2025, 06:31 | Cancer Center Near Me
Cancer Center Near Me: Dana-Farber Cancer Institute
Finding a trusted cancer center near you is a critical step in ensuring high-quality care…
Apr 10, 2025, 07:32 | Blog
Narjust Florez: I’m starting a new position as Co-Director Young Lung Cancer Program at Dana-Farber Cancer Institute
Narjust Florez, Associate Director of the Cancer Care Equity Program and a Thoracic Medical Oncologist at…
Apr 10, 2025, 07:13 | Blog
Herbert Loong: Jacob Sands shares his experiences and insights in management of SCLC
Herbert Loong, Chair-Elect of the International Affairs Committee at American Society of Clinical Oncology (ASCO), shared…
Apr 9, 2025, 08:29 | Stories
Jimmy Fund Golf presented by Mohegan Sun helps raise money for cancer research and care at Dana-Farber Cancer Institute
The Jimmy Fund shared a post on X: "Bob Desautels started a Jimmy Fund Golf…
Apr 5, 2025, 13:05 | Blog
Dana-Farber Cancer Institute explored the rising rates of cancer in women under 65 - Florez Lab
Florez Lab shared a post on X: "Why is cancer on the rise in young…
Apr 3, 2025, 14:33 | Blog
Benjamin Ebert: Thank you to everyone who attended the celebration of the Dana-Farber Campaign
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared a post on LinkedIn by…
Apr 2, 2025, 16:47 | Blog
Matt Yurgelun: There’s still time to join us for our Dana-Farber Cancer Institute's Lynch Syndrome Scientific Symposium
Matt Yurgelun, Senior Physician at Dana-Farber Cancer Institute, shared on X: "There’s still time to…
Mar 31, 2025, 08:53 | Blog
Sarah Sammons: A few highlights from my ADC resistance talk at LACOG-GBECAM 2025
Sarah Sammons, Breast Medical Oncologist at Dana-Farber Cancer Institute, shared on LinkedIn: "A few highlights…
Mar 30, 2025, 04:13 | Blog
Brian Alexander: Excited to join the board of MassBio
Brian Alexander, CEO of Foundation Medicine, reshared a post on LinkedIn: "I am tremendously excited…
Mar 29, 2025, 10:00 | Societies
Scientific Abstract submissions are open for the 22nd SIO International Conference
Society for Integrative Oncology shared a post on LinkedIn: "We are excited to announce the…
Mar 29, 2025, 08:38 | Career
From Patient to Physician: Dr. Pedro Vianna's Journey - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "When Pedro Vianna, MD, was 5, his mother took…
Mar 29, 2025, 08:18 | Blog
Lauren Knelson: Updates to Cancer Survivorship - Optimizing Care and Outcomes course
Lauren Knelson, Program Manager III at Dana-Farber Cancer Institute for Adult Survivorship Program, posted on…
Mar 27, 2025, 15:09 | Blog
Shushan Hovsepyan: Michael Wagner on Current and Promising Angiosarcoma Treatments
Shushan Hovsepyan, Editor-in-Chief of OncoDaily Medical Journal, shared a post on LinkedIn: "Here’s your weekly digest…
Mar 24, 2025, 13:48 | Blog
Paolo Tarantino: St. Gallen Consensus 2025 - 10 key votes
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "The…
Mar 23, 2025, 15:25 | Blog
Michael Serzan: Lynch Syndrome Awareness Day at Dana Farber Cancer Institute
Michael Serzan, Genitourinary Medical Oncologist at Dana Farber Cancer Institute, shared a post on X:…
Mar 20, 2025, 07:28 | Blog
Paolo Tarantino: The 24th Annual IBC East Conference is coming soon
Paolo Tarantino, Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "The…
Mar 18, 2025, 12:33 | Science
Sina Neyazi: Avapritinib as a novel targeted treatment for pediatric high-grade glioma with PDGFRA alterations
Sina Neyazi, Postdoctoral Research Fellow at Dana-Farber Cancer Institute, shared an article by Lisa Mayr, et al.…
Mar 13, 2025, 07:15 | Blog
Why We Need to HearHer - LUNGevity Foundation
LUNGevity Foundation posted on LinkedIn: "'Even when the diagnosis is hard to accept, there is…
Mar 12, 2025, 14:41 | Blog
A webinar on the latest in colorectal cancer prevention and screening by Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Join us for a free webinar hosted…
Mar 11, 2025, 07:33 | Blog
Teatime with SHE featuring Zainab Shinkafi-Bagudu and Navid Madani
Zainab Shinkafi-Bagudu, UICC President-Elect of 2024-2026, shared a post on LinkedIn: "Join us at the…
Mar 4, 2025, 08:01 | Blog
Dana-Farber has elected the largest cohort of physician-investigators to the 2025 class of ASCI
Dana-Farber Cancer Institute shared a post on LinkedIn "Dana-Farber has elected the largest cohort of…
Mar 3, 2025, 12:37 | Blog
Expanding CAR-T Therapy Access: A Collaboration between Boston and Cairo - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "In the U.S., CAR-T cell therapy has…
Mar 1, 2025, 20:21 | Blog
Pratiti Bandopadhayay: Join our efforts to find better treatments for children with pediatric gliomas
Pratiti Bandopadhayay, Pediatric Neuro-Oncologist at Dana-Farber Cancer Institute and Broad Institute, shared a post on…
Feb 28, 2025, 08:09 | Blog
Sergio Cifuentes Canaval: Treatment Beyond ADCs Progression and ADCs Sequencing
Sergio Cifuentes Canaval, Cancer Research Project Manager at CENEIT Mexico, shared a post on LinkedIn:…
Feb 28, 2025, 08:09 | Blog
Paolo Tarantino: The SERENA6 phase 3 trial is positive
Paolo Tarantino,  Advanced Research Fellow at Dana-Farber Cancer Institute, shared a post on X: "The…
Feb 26, 2025, 15:34 | Blog
Sarah Louden: University of Kansas Breast Cancer Year in Review
Sarah Louden, CEO and Founder of Total Health Oncology, shared a post on LinkedIn: "University…
Feb 25, 2025, 08:56 | Blog
Dana-Farber Cancer Institute was recognized as one of Women’s Choice Award’s Best Hospitals for Cancer Care 2025
Dana-Farber Cancer Institute shared a post on LinkedIn: "We’re proud and honored to be recognized…
Feb 24, 2025, 08:44 | Blog
Narjust Florez: Lung Cancer Cases Rising in Young Women of Asian and Latina Descent
Narjust Florez, Associate Director of the Cancer Care Equity Program and Thoracic Medical Oncologist at…
Feb 23, 2025, 12:27 | Career
Kimberly Stegmaier has been named as Pediatric Oncology Chair at Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Kimberly Stegmaier, MD, has been named as…
Feb 19, 2025, 13:58 | Blog
Paolo Tarantino: 8 ADC breast cancer trials expected to reshape practice in 2025
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared a post on X: "2025…
Feb 18, 2025, 14:40 | Blog
Dana-Farber Cancer Institute joined the international Alliance for Cancer Early Detection
Timothy Rebbeck, Vincent L. Gregory, Jr. Professor of Cancer Prevention at Harvard T.H. Chan School…
Feb 17, 2025, 05:06 | Blog
The Second Global OncoThon: Highlights Part 4
OncoDaily and the International Society of Pediatric Oncology (SIOP)  hosted the Second Global OncoThon, a 24-hour virtual event on February 15,…
Feb 12, 2025, 16:51 | Career
2025 FASCO Recipients Part – 2
The American Society of Clinical Oncology (ASCO) recently released the FASCO recipients for 2025. The FASCO (Fellow…
Feb 9, 2025, 15:31 | Science
Guilherme Nader Marta: The current role of anthracyclines in early breast cancer treatment
Guilherme Nader Marta, Advanced Clinical Fellow at Dana-Farber Cancer Institute, shared an article on X:…
Feb 8, 2025, 07:09 | Science
Srinivas Viswanathan: TFE3 fusion drives a key oxidative phosphorylation in translocation RCC
Srinivas Viswanathan, Principal Investigator at Dana-Farber Cancer Institute and an Assistant Professor at Harvard Medical…
Feb 7, 2025, 21:14 | Blog
Workshop Submissions are open for the 22nd SIO International Conference
Society for Integrative Oncology posted on X: "We’re thrilled to open Workshop Submissions for the…
Feb 7, 2025, 16:02 | Career
Recipients of the Conquer Cancer 2025 Genitourinary Cancers Symposium Merit Awards
The Conquer Cancer 2025 Genitourinary Cancers Symposium Merit Awards have been awarded to first authors…
Feb 7, 2025, 13:45 | Blog
Connecting with healthcare leaders transforming cancer care in the UAE region - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Arab Health 2025 was an incredible opportunity…
Feb 7, 2025, 08:42 | Science
Shai Shimony: Biology and Management of NPM1 Mutated AML
Shai Shimony, Advanced Clinical Fellow at Dana-Farber Cancer Institute, shared an article by Evan C.…
Feb 5, 2025, 22:09 | Blog
Together, a cancer-free world is possible - The Jimmy Fund
The Jimmy Fund posted on LinkedIn: "This World Cancer Day – and every day –…
Feb 3, 2025, 14:13 | Blog
David Barbie and his research team have been awarded the inaugural IASLC and LCRF Team Science Research Grant
Dana-Farber Cancer Institute posted on LinkedIn: "David Barbie, MD, and his research team have been…
Feb 1, 2025, 08:22 | Blog
Carmine Valenza, a member of the 2024-2025 PCE Outreach Team - Program in Clinical Effectiveness
Program in Clinical Effectiveness shared a post on LinkedIn: "Meet Carmine Valenza, a member of…
Jan 30, 2025, 08:53 | Blog
Karen Merritt: Hoping for labelling updates to recommend pre-treatment DPD deficiency testing
Karen Merritt, Patient Advocate-Advocates for Universal DPD, shared a post on LinkedIn: "After the FDA…
Jan 30, 2025, 08:44 | Science
Final analysis of the PRECIOUS phase 3 trial
Paolo Tarantino, Clinical Fellow at Dana-Farber Cancer Institute and Harvard Medical School, shared an article by…
Jan 29, 2025, 12:51 | Blog
Sarah Louden: Join Total Health for "Best of Heme" on February 10th
Sarah Louden, CEO & Founder of Total Health, shared a post on LinkedIn: "Interested in…
Jan 29, 2025, 12:07 | Blog
Celebrating Life: A Stem Cell Recipient Meets Her Donor at the NMDP ONE Forum - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Each year at the NMDP’s (formerly known…
Jan 29, 2025, 09:43 | Blog
Paolo Tarantino: "Not If, But When" by Maurizio Scaltriti
Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn: "Oncology…
Jan 28, 2025, 10:25 | Blog
I found a lump on my body. Now what? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute posted on LinkedIn: "I found a lump on my body. Now what?…
Jan 28, 2025, 09:17 | Blog
Adult and Pediatric Stem Cell Transplant Programs Achieve +1 in 2024 CIBMTR Report - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "We are proud to announce that both…
Jan 27, 2025, 09:14 | Blog
Workshop submissions are open for the 22nd International Conference of The Society for Integrative Oncology
Society for Integrative Oncology shared a post on LinkedIn: "We are excited to announce the…
Jan 26, 2025, 15:31 | Career
Charles W.M. Roberts - Candidate for Board of Directors of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote…
Jan 26, 2025, 14:42 | Career
Timothy R. Rebbeck - Candidate for Board of Directors of AACR
The voting for the 2025 AACR Annual Election is now open, where members will vote…
Jan 26, 2025, 13:43 | Blog
Dana-Farber celebrated the life and legacy of Rev. Dr. Martin Luther King, Jr. during its 23rd annual MLK event - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "In words, dance, song, and story, Dana-Farber…
Jan 25, 2025, 16:19 | Science
Paolo Tarantino: Evolutions in the treatment of HER2+ breast cancer
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, shared an article by Tess A. O'Meara…
Jan 25, 2025, 12:41 | Blog
Rare Germline Variants and Pediatric Solid Tumor Risk: Join the SIOP Webinar
International Society of Paediatric Oncology (SIOP) shared the following on LinkedIn: “Join us for ‘Rare…
Jan 23, 2025, 13:56 | Science
2 Neoadjuvant chemo-IO trials for high-risk ER+ BC
Paolo Tarantino, Advanced research fellow at Dana-Farber Cancer Institute, shared an article by Fatima Cardoso…
Jan 23, 2025, 09:37 | Blog
Experiences and challenges of young adult patients with CRC - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Clinicians and researchers have recognized a disturbing…
Jan 22, 2025, 15:27 | Blog
The Future of Integrative Oncology: Bridging Cultures, Embracing Innovation and Fostering Unity - SIO
Society for Integrative Oncology shared a post on LinkedIn: "We are excited to announce the…
Jan 20, 2025, 02:16 | Science
Tucatinib and trastuzumab in HER2-mutated metastatic breast cancer
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, shared an article by Alicia F. C.…
Jan 19, 2025, 15:36 | Blog
Paolo Tarantino: How do you plan to use Datopotamab Deruxtecan for HR+/HER2- MBC?
Paolo Tarantino, Research fellow at Dana-Farber Cancer Institute, shared a post on X: "Dato-DXd is…
Jan 18, 2025, 14:00 | Insight
2025 Transatlantic Exchange by Dana-Farber and Gustave Roussy to Focus on Radioligand Therapy
Dana-Farber Cancer Institute and Gustave Roussy (Villejuif, France) have announced the 2025 Transatlantic Exchange scientific…
Jan 16, 2025, 09:28 | Blog
Glenn J. Hanna: Multidisciplinary approach to treat HPV-driven oropharyngeal cancer
Glenn J. Hanna, Medical Oncologist and Physician at Dana-Farber Cancer Institute shared a post on…
Jan 16, 2025, 08:14 | Career
Narjust Florez was named as a health equity champion by Boston Business Journal
Florez Lab shared a post on X: “Narjust Florez has been named a Health Equity…
Jan 15, 2025, 14:29 | Blog
Findings related to CDK4/6 inhibitors and antibody drug conjugates presented at SABCS 2024 - Cancer Network
Cancer Network shared a post on X: "Paolo Tarantino, MD, and Matteo Lambertini, MD, PhD…
Jan 15, 2025, 13:18 | Blog
Dana-Farber Cancer Institute - One of the first clinical trials in the US to test 'memory like' NK cells in ovarian cancer
Dana-Farber Cancer Institute shared on LinkedIn: "Investigators at Dana-Farber are opening a new clinical trial to…
Jan 15, 2025, 11:08 | Blog
Why Dana-Farber Direct Connect? - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "When it comes to cancer treatment, where…
Jan 15, 2025, 07:22 | Societies
Benjamin Ebert: Excited to launch the Center for RAS Therapeutics
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared a post on LinkedIn by…
Jan 12, 2025, 15:08 | Blog
Dana-Farber Cancer Institute has been named one of Forbes' Top 100 Charities
The 2024 Forbes list of America’s Top 100 Charities highlights the significant impact of major…
Jan 10, 2025, 23:34 | Science
H. Moses Murdock: How I Treat AML relapse after allogeneic HCT
H. Moses Murdock, Hematology/Oncology fellow at Dana-Farber Cancer Institute, shared a post on X about…
Jan 10, 2025, 08:43 | Blog
Five Efforts by the Centers for Early Detection and Interception - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Dana-Farber’s Centers for Early Detection and Interception…
Jan 9, 2025, 15:58 | Insight
Dana-Farber Cancer Institute has officially launched the Center for RAS Therapeutics
RAS Therapeutics is a multidisciplinary initiative designed to enhance scientific research, improve treatment strategies, and…
Jan 6, 2025, 16:49 | Blog
Tackling Disparities in Childhood Cancer Outcomes: The IGNITE Consortium's Mission
Dr. Kira Bona and her team at the Dana-Farber lab have discovered a troubling truth:…
Jan 5, 2025, 17:42 | Career
Alexandra Bailey's journey to Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Four years ago, Alexandra Bailey, MD, received…
Jan 5, 2025, 17:04 | Career
William Hahn Named to Becker's Healthcare COOs to Know List
Dana-Farber Cancer Institute shared a post on LinkedIn: “Congratulations to William Hahn on being named…
Dec 28, 2024, 18:19 | Blog
Benjamin Ebert: Privileged to end this year a few months into my tenure as President and CEO of Dana-Farber Cancer Institute
Benjamin Ebert, President and CEO of Dana-Farber Cancer Institute, shared a post on LinkedIn: "With…
Dec 27, 2024, 18:27 | Blog
A CRISPR-based rapid molecular diagnostic for two forms of leukemia - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute shared a post on LinkedIn: "Researchers at Dana-Farber have created a CRISPR-based…
Dec 27, 2024, 07:50 | Blog
Ken Kehl: A new open-source approach to match patients with cancer to potential clinical trials
Ken Kehl, Assistant Professor of Medicine at Harvard Medical School and Physician at Dana-Farber Cancer…
Dec 24, 2024, 11:36 | Blog
How T-cells recognize foreign proteins has changed the way we think about the immune response
Dana-Farber Cancer Institute shared on LinkedIn: "'Humans are difficult,' said Mark Davis,  director of the Stanford…
All: 539 Posts: 1 - 100
Special Coverage